3. prevent disease
Tylvalosin Tartrate Premix is used for mycoplasma infection in pigs and chickens.
Main ingredient: Tyvanectin tartrate
Properties: This product is light yellow-brown or yellow-brown powder.
Pharmacological action: Tyvanectin tartrate is a special antibiotic for macrolides, which inhibits the synthesis of bacterial protein, thereby ，Inhibit the reproduction of bacteria. Its antibacterial spectrum is similar to tylosin, for example, it has a strong antibacterial effect on Staphylococcus aureus. This product is effective against Gram-positive bacteria resistant to other antibiotics.
Negative bacteria have little effect and have strong antibacterial activity against Mycoplasma septicum and Mycoplasma synovialis. Bacteria to this product not easy to develop drug resistance.
(1) It has antagonistic effect on the effects of aminodemands and lincomycins, so they should not be used together.
(2) When β-lactam drugs are combined with this product (as a bacteriostatic agent), it can interfere with the former，It is not suitable to use the two at the same time for diseases that require rapid bactericidal effect.
Role and use: antibiotic drugs. Used for mycoplasma infection in pigs and chickens.
Usage and Dosage: Based on this product. Mixed feeding: 1~1.5kg for pigs per 1000kg feed; 2-6kg for chickens, continuous use for 7 days.
(1) Banned during laying hens.
(2) It should not be combined with penicillins.
(3) Avoid contact with this product for non-treated animals: avoid direct contact with eyes and skin,
Withdrawal period: 3 days for pigs and 5 days for chickens.
product name: Tylvalosin Tartrate Premix
Main ingredients: Tylvalosin tartrate
product status: powder
Scope of use: Farmed animals
Product specification: 100g/bag
Validity period: 2 years
Based on this product. Mixed feeding: 1~1.5kg per 1000kg feed, chicken 2~6kg per 1000kg feed. Use for 7 days.
This product cannot be mixed or transported with toxic or hazardous materials.
Tylvalosin Tartrate Premix can be used if the following symptoms occur：
Staphylococcus aureus infection